Who owns TYRA BIOSCIENCES INC?
- Ticker: TYRA
- CUSIP Number: 90240b106
Tip: Access positions for across all investors
Analyze quarterly positions in Tyra Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Tyra Biosciences stock
Who bought or sold TYRA BIOSCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 10M | $171M | 44% | Mar 2024 |
|
| Boxer Capital | 6.4M | $106M | 0% | Mar 2024 |
|
| BVF | 4.7M | $76M | 70% | Mar 2024 |
|
| Canaan Partners XI | 4.4M | $72M | 0% | Mar 2024 |
|
| Nextech Invest | 4.1M | $67M | 61% | Mar 2024 |
|
| FMR | 4.0M | $65M | 2% | Mar 2024 |
|
| Fairmount Funds Management | 1.4M | $23M | 0% | Mar 2024 |
|
| BlackRock | 1.0M | $17M | 16% | Mar 2024 |
|
| 5AM Venture Management | 939k | $15M | 69% | Mar 2024 |
|
| Vanguard Group | 900k | $15M | 19% | Mar 2024 |
|
| Frazier Life Sciences Management | 832k | $14M | -19% | Mar 2024 |
|
| OrbiMed Advisors | 769k | $13M | 100% | Mar 2024 |
|
| Perceptive Advisors | 669k | $11M | 86% | Mar 2024 |
|
| Sio Capital Management | 536k | $8.8M | 100% | Mar 2024 |
|
| Kynam Capital Management | 515k | $8.4M | 51% | Mar 2024 |
|
| Geode Capital Management | 417k | $6.8M | 33% | Mar 2024 |
|
| First Turn Management | 381k | $6.3M | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 381k | $6.2M | -5% | Mar 2024 |
|
| ExodusPoint Capital Management | 272k | $4.5M | 100% | Mar 2024 |
|
| Northern Trust | 157k | $2.6M | 11% | Mar 2024 |
|
| Charles Schwab Investment Management | 152k | $2.5M | 38% | Mar 2024 |
|
| Wellington Management Company | 102k | $1.4M | 9% | Dec 2023 |
|
| Auour Investments | 85k | $1.4M | 0% | Mar 2024 |
|
| Oppenheimer & Co | 60k | $977k | 100% | Mar 2024 |
|
| Victory Capital Management | 48k | $789k | -4% | Mar 2024 |
|
| Bank of New York Mellon | 44k | $717k | 4% | Mar 2024 |
|
| Two Sigma Investments | 42k | $685k | 100% | Mar 2024 |
|
| Morgan Stanley | 35k | $578k | 93% | Mar 2024 |
|
| Bank of America Corporation | 33k | $542k | 49% | Mar 2024 |
|
| New York State Common Retirement Fund | 32k | $527k | 698% | Mar 2024 |
|
| ADAR1 Capital Management | 28k | $464k | 100% | Mar 2024 |
|
| Nuveen Asset Management | 26k | $422k | 37% | Mar 2024 |
|
| American Century Companies | 25k | $409k | 100% | Mar 2024 |
|
| Citadel Advisors | 21k | $346k | 100% | Mar 2024 |
|
| Rhumbline Advisers | 21k | $344k | -2% | Mar 2024 |
|
| Legato Capital Management | 20k | $332k | 100% | Mar 2024 |
|
| Marshall Wace | 20k | $322k | -35% | Mar 2024 |
|
| Walleye Trading Advisors | 17k | $277k | 100% | Mar 2024 |
|
| Exchange Traded Concepts | 16k | $263k | 68% | Mar 2024 |
|
| Fishman Jay A | 15k | $246k | 100% | Mar 2024 |
|
| UBS Group | 14k | $232k | 185% | Mar 2024 |
|
| Goldman Sachs Group | 14k | $231k | 100% | Mar 2024 |
|
| Hudson Bay Capital Management | 13k | $218k | 100% | Mar 2024 |
|
| PDT Partners | 12k | $200k | 100% | Mar 2024 |
|
| Dimensional Fund Advisors | 11k | $176k | 1% | Mar 2024 |
|
| Sepio Capital | 11k | $147k | 0% | Dec 2023 |
|
| Baker Bros. Advisors | 11k | $174k | 0% | Mar 2024 |
|
| Barclays | 9.9k | $161k | -49% | Mar 2024 |
|
| MetLife Investment Advisors | 7.7k | $107k | 0% | Dec 2023 |
|
| Citigroup | 7.1k | $117k | 250% | Mar 2024 |
|
| Qube Research & Technologies | 7.0k | $115k | 100% | Mar 2024 |
|
| American International | 7.0k | $96k | 0% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 6.0k | $99k | -3% | Mar 2024 |
|
| Wells Fargo & Company | 4.7k | $78k | 16% | Mar 2024 |
|
| Federated Investors | 2.1k | $29k | 1244% | Dec 2023 |
|
| California State Teachers Retirement System | 1.4k | $23k | -54% | Mar 2024 |
|
| Legal & General Group | 1.3k | $21k | 0% | Mar 2024 |
|
| Summit Investment Advisors | 940.00 | $15k | 0% | Mar 2024 |
|
| Metropolitan Life Insurance Company | 814.00 | $11k | 0% | Dec 2023 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 700.00 | $11k | 100% | Mar 2024 |
|
| Ikarian Capital | 501.00 | $8.2k | -99% | Mar 2024 |
|
| Amalgamated Bank | 424.00 | $7.0k | -71% | Mar 2024 |
|
| Royal Bank of Canada | 320.00 | $0 | -92% | Mar 2024 |
|
| Tower Research Capital | 144.00 | $2.4k | -83% | Mar 2024 |
|
| Russell Investments | 126.00 | $2.1k | 563% | Mar 2024 |
|
| Simplex Trading | 100.00 | $1.0k | 100% | Mar 2024 |
|
| Pnc Financial Services | 58.00 | $951.002800 | 0% | Mar 2024 |
|
| NISA Investment Advisors | 34.00 | $558.001200 | 112% | Mar 2024 |
|
| GAMMA Investing | 16.00 | $262.000000 | 0% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 2.00 | $32.000000 | 100% | Mar 2024 |
|
| CWM | 1.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Tyra Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Woodline Partners | Sep 2023 | 410k | $5.7M |
| EcoR1 Capital | Dec 2023 | 137k | $1.9M |
| Mariner Wealth Advisors | Dec 2023 | 22k | $307k |
| LPL Financial | Sep 2023 | 15k | $200k |
| Susquehanna International | Sep 2023 | 12k | $164k |
| Artia Global Partners | Dec 2023 | 10k | $142k |
| AJOVista | Dec 2023 | 4.2k | $59k |